Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM BSE: 500420

₹4738.50

+88.50 (1.90%)

Fri, 06 Nov 2026, 10:06 pm

MTF 5xInvest in Torrent Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)176294.19

PE Ratio77.64

Dividend0.82

Health Technology

Pharmaceuticals: Major

24.5K

Torrent Pharmaceuticals Financials

Income Statement Balance Sheet Cashflow

Particulars	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total revenue	9.34B	12.62B	13.12B	15.85B	18.28B	21.22B	25.89B	30.45B	40.23B	45.68B	65.44B	57.32B	59.18B	75.89B	78.53B	79.52B	84.81B	95.37B	106.05B	113.58B
Gross profit	1.34B	5.01B	2.70B	7.08B	8.00B	8.70B	10.38B	12.07B	18.27B	19.65B	37.95B	25.64B	26.07B	28.86B	32.10B	32.47B	33.65B	39.49B	46.76B	51.03B
Operating expenses (excl. COGS)	-829.81M	-4.09B	-1.42B	-4.93B	-5.21B	-6.27B	-6.68B	-7.38B	-9.71B	-11.64B	-12.68B	-15.21B	-16.88B	-15.44B	-17.05B	-14.16B	-16.08B	-18.36B	-21.42B	-22.53B
Selling/general/admin expenses, total	—	-4.10B	—	-4.28B	-5.19B	-5.52B	-6.94B	-7.30B	-10.16B	-12.00B	-13.91B	-15.21B	-16.88B	-15.44B	-17.05B	-14.16B	-15.62B	-18.36B	-21.42B	-22.53B
Research & development	-564.24M	-770.15M	-971.57M	-1.12B	-1.20B	-1.39B	-1.17B	-111.14M	-1.31B	-1.54B	-2.09B	-3.59B	-3.44B	-5.38B	-4.94B	-4.87B	-5.16B	-5.16B	-5.27B	-5.81B
Selling/general/admin expenses, other	—	-3.32B	—	-3.16B	-3.98B	-4.13B	-5.77B	-7.19B	-8.85B	-10.46B	-11.82B	-11.62B	-13.43B	-10.06B	-12.11B	-9.29B	-10.46B	-13.20B	-16.15B	-16.72B
Other operating expenses, total	-829.81M	8.81M	-1.42B	-651.23M	-20.41M	-751.26M	260.41M	-81.60M	458.40M	355.20M	1.22B	0	0	0	0	0	-456.80M	0	0	0
Operating income	505.40M	919.16M	1.28B	2.15B	2.80B	2.43B	3.40B	4.69B	8.04B	7.61B	24.05B	10.43B	9.20B	13.42B	15.06B	18.31B	17.57B	21.13B	25.34B	28.50B
Non-operating income, total	245.80M	147.88M	188.05M	-267.04M	676.52M	995.49M	187.06M	1.13B	399.00M	1.78B	-612.10M	465.80M	189.80M	-7.81B	-3.19B	-3.05B	-5.32B	-2.66B	-1.81B	-1.77B
Interest expense, net of interest capitalized	-99.54M	-236.44M	-228.56M	-392.96M	-291.02M	-386.50M	-394.54M	-338.00M	-586.30M	-1.75B	-1.84B	-2.06B	-3.08B	-5.04B	-4.51B	-3.53B	-2.55B	-3.33B	-3.54B	-2.52B
Interest capitalized	0	0	0	0	0	0	0	0	0	0	553.00M	272.70M	0	0	0	0	0	0	0	40.10M
Non-operating income, excl. interest expenses	345.34M	384.32M	416.61M	242.76M	967.54M	1.38B	1.24B	1.91B	848.80M	3.54B	2.98B	2.66B	3.40B	-497.50M	1.35B	487.10M	1.62B	716.30M	1.85B	996.80M
Non-operating interest income	38.15M	74.42M	32.13M	202.84M	125.93M	265.94M	328.30M	338.10M	274.20M	145.80M	60.00M	48.50M	66.60M	164.10M	79.60M	50.70M	71.50M	147.80M	114.80M	201.90M
Miscellaneous non-operating expense	307.19M	309.90M	384.47M	39.92M	841.61M	1.12B	906.95M	1.57B	574.60M	3.39B	2.92B	2.61B	3.29B	-733.30M	1.27B	436.40M	1.55B	555.00M	1.74B	789.90M
Unusual income/expense	—	—	—	-116.83M	—	—	-653.64M	-445.50M	136.50M	—	-1.75B	-141.60M	-124.20M	-2.27B	-39.90M	-4.00M	-4.39B	-44.20M	-128.40M	-241.80M
Pretax income	751.20M	1.07B	1.47B	1.89B	3.47B	3.43B	3.59B	5.82B	8.44B	9.40B	23.43B	10.88B	9.31B	5.62B	11.87B	15.26B	12.26B	18.47B	23.52B	26.73B
Taxes	-189.09M	-131.91M	-118.84M	-44.01M	-1.16B	-725.09M	-723.15M	-1.47B	-1.80B	-1.89B	-6.10B	-1.55B	-2.53B	-1.25B	-1.62B	-2.74B	-4.49B	-6.02B	-6.96B	-7.62B
Non-controlling/minority interest	0	0	0	0	0	41.00K	-22.61M	-21.50M	-300.00K	-300.00K	-300.00K	-300.00K	-300.00K	-300.00K	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Net income	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	760.58M	1.25B	1.67B	2.58B	3.46B	3.06B	4.52B	5.51B	9.43B	9.91B	27.65B	13.37B	13.28B	19.57B	21.57B	24.88B	24.19B	28.15B	33.29B	36.45B
EBIT	505.40M	919.16M	1.28B	2.15B	2.80B	2.43B	3.70B	4.69B	8.56B	8.01B	25.27B	10.43B	9.20B	13.42B	15.06B	18.31B	17.57B	21.13B	25.34B	28.50B
Total operating expenses	-8.83B	-11.71B	-11.84B	-13.69B	-15.48B	-18.79B	-22.50B	-25.76B	-32.19B	-38.06B	-40.17B	-46.89B	-49.99B	-62.47B	-63.47B	-61.21B	-67.24B	-74.24B	-80.72B	-85.09B
Prepaid expenses	80.11M	88.66M	91.71M	46.10M	54.25M	115.17M	—	—	—	—	218.20M	237.20M	370.10M	404.00M	526.40M	548.00M	514.60M	666.90M	589.50M	631.10M
Deferred income, current	—	—	—	—	—	—	—	—	—	—	—	98.10M	99.90M	96.20M	116.60M	87.30M	101.30M	13.30M	45.00M	19.40M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	222.00M	368.20M	368.20M	529.30M	644.60M	1.46B
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	575.72M	694.82M	761.84M	683.31M	621.91M	617.05M	770.87M	569.10M	474.80M	1.89B	2.89B	4.19B	6.13B	8.27B	—	—	1.94B	4.02B	6.56B	8.29B
Deferred income, non-current	0	0	0	—	—	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	16.01M	35.02M	3.70M	4.00M	4.30M	4.60M	4.90M	5.20M	0	0	0	0	0	0	0
Change in accrued expenses	0	—	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	-193.15M	-531.69M	-1.08M	-331.86M	-410.15M	-591.16M	-1.37B	-834.40M	-2.67B	-2.00B	-8.40B	-2.04B	-2.65B	-3.10B	-7.18B	-3.38B	-6.77B	-8.63B	-10.15B	-10.83B
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Particulars	Mar 2006	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total revenue	9.34B	12.62B	13.12B	15.85B	18.28B	21.22B	25.89B	30.45B	40.23B	45.68B	65.44B	57.32B	59.18B	75.89B	78.53B	79.52B	84.81B	95.37B	106.05B	113.58B
Gross profit	1.34B	5.01B	2.70B	7.08B	8.00B	8.70B	10.38B	12.07B	18.27B	19.65B	37.95B	25.64B	26.07B	28.86B	32.10B	32.47B	33.65B	39.49B	46.76B	51.03B
Operating expenses (excl. COGS)	-829.81M	-4.09B	-1.42B	-4.93B	-5.21B	-6.27B	-6.68B	-7.38B	-9.71B	-11.64B	-12.68B	-15.21B	-16.88B	-15.44B	-17.05B	-14.16B	-16.08B	-18.36B	-21.42B	-22.53B
Selling/general/admin expenses, total	—	-4.10B	—	-4.28B	-5.19B	-5.52B	-6.94B	-7.30B	-10.16B	-12.00B	-13.91B	-15.21B	-16.88B	-15.44B	-17.05B	-14.16B	-15.62B	-18.36B	-21.42B	-22.53B
Research & development	-564.24M	-770.15M	-971.57M	-1.12B	-1.20B	-1.39B	-1.17B	-111.14M	-1.31B	-1.54B	-2.09B	-3.59B	-3.44B	-5.38B	-4.94B	-4.87B	-5.16B	-5.16B	-5.27B	-5.81B
Selling/general/admin expenses, other	—	-3.32B	—	-3.16B	-3.98B	-4.13B	-5.77B	-7.19B	-8.85B	-10.46B	-11.82B	-11.62B	-13.43B	-10.06B	-12.11B	-9.29B	-10.46B	-13.20B	-16.15B	-16.72B
Other operating expenses, total	-829.81M	8.81M	-1.42B	-651.23M	-20.41M	-751.26M	260.41M	-81.60M	458.40M	355.20M	1.22B	0	0	0	0	0	-456.80M	0	0	0
Operating income	505.40M	919.16M	1.28B	2.15B	2.80B	2.43B	3.40B	4.69B	8.04B	7.61B	24.05B	10.43B	9.20B	13.42B	15.06B	18.31B	17.57B	21.13B	25.34B	28.50B
Non-operating income, total	245.80M	147.88M	188.05M	-267.04M	676.52M	995.49M	187.06M	1.13B	399.00M	1.78B	-612.10M	465.80M	189.80M	-7.81B	-3.19B	-3.05B	-5.32B	-2.66B	-1.81B	-1.77B
Interest expense, net of interest capitalized	-99.54M	-236.44M	-228.56M	-392.96M	-291.02M	-386.50M	-394.54M	-338.00M	-586.30M	-1.75B	-1.84B	-2.06B	-3.08B	-5.04B	-4.51B	-3.53B	-2.55B	-3.33B	-3.54B	-2.52B
Interest capitalized	0	0	0	0	0	0	0	0	0	0	553.00M	272.70M	0	0	0	0	0	0	0	40.10M
Non-operating income, excl. interest expenses	345.34M	384.32M	416.61M	242.76M	967.54M	1.38B	1.24B	1.91B	848.80M	3.54B	2.98B	2.66B	3.40B	-497.50M	1.35B	487.10M	1.62B	716.30M	1.85B	996.80M
Non-operating interest income	38.15M	74.42M	32.13M	202.84M	125.93M	265.94M	328.30M	338.10M	274.20M	145.80M	60.00M	48.50M	66.60M	164.10M	79.60M	50.70M	71.50M	147.80M	114.80M	201.90M
Miscellaneous non-operating expense	307.19M	309.90M	384.47M	39.92M	841.61M	1.12B	906.95M	1.57B	574.60M	3.39B	2.92B	2.61B	3.29B	-733.30M	1.27B	436.40M	1.55B	555.00M	1.74B	789.90M
Unusual income/expense	—	—	—	-116.83M	—	—	-653.64M	-445.50M	136.50M	—	-1.75B	-141.60M	-124.20M	-2.27B	-39.90M	-4.00M	-4.39B	-44.20M	-128.40M	-241.80M
Pretax income	751.20M	1.07B	1.47B	1.89B	3.47B	3.43B	3.59B	5.82B	8.44B	9.40B	23.43B	10.88B	9.31B	5.62B	11.87B	15.26B	12.26B	18.47B	23.52B	26.73B
Taxes	-189.09M	-131.91M	-118.84M	-44.01M	-1.16B	-725.09M	-723.15M	-1.47B	-1.80B	-1.89B	-6.10B	-1.55B	-2.53B	-1.25B	-1.62B	-2.74B	-4.49B	-6.02B	-6.96B	-7.62B
Non-controlling/minority interest	0	0	0	0	0	41.00K	-22.61M	-21.50M	-300.00K	-300.00K	-300.00K	-300.00K	-300.00K	-300.00K	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Net income	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	562.11M	935.13M	1.35B	1.84B	2.31B	2.70B	2.84B	4.33B	6.64B	7.51B	17.33B	9.34B	6.78B	4.36B	10.25B	12.52B	7.77B	12.45B	16.56B	19.11B
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	760.58M	1.25B	1.67B	2.58B	3.46B	3.06B	4.52B	5.51B	9.43B	9.91B	27.65B	13.37B	13.28B	19.57B	21.57B	24.88B	24.19B	28.15B	33.29B	36.45B
EBIT	505.40M	919.16M	1.28B	2.15B	2.80B	2.43B	3.70B	4.69B	8.56B	8.01B	25.27B	10.43B	9.20B	13.42B	15.06B	18.31B	17.57B	21.13B	25.34B	28.50B
Total operating expenses	-8.83B	-11.71B	-11.84B	-13.69B	-15.48B	-18.79B	-22.50B	-25.76B	-32.19B	-38.06B	-40.17B	-46.89B	-49.99B	-62.47B	-63.47B	-61.21B	-67.24B	-74.24B	-80.72B	-85.09B
Prepaid expenses	80.11M	88.66M	91.71M	46.10M	54.25M	115.17M	—	—	—	—	218.20M	237.20M	370.10M	404.00M	526.40M	548.00M	514.60M	666.90M	589.50M	631.10M
Deferred income, current	—	—	—	—	—	—	—	—	—	—	—	98.10M	99.90M	96.20M	116.60M	87.30M	101.30M	13.30M	45.00M	19.40M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	222.00M	368.20M	368.20M	529.30M	644.60M	1.46B
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	575.72M	694.82M	761.84M	683.31M	621.91M	617.05M	770.87M	569.10M	474.80M	1.89B	2.89B	4.19B	6.13B	8.27B	—	—	1.94B	4.02B	6.56B	8.29B
Deferred income, non-current	0	0	0	—	—	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	16.01M	35.02M	3.70M	4.00M	4.30M	4.60M	4.90M	5.20M	0	0	0	0	0	0	0
Change in accrued expenses	0	—	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	-193.15M	-531.69M	-1.08M	-331.86M	-410.15M	-591.16M	-1.37B	-834.40M	-2.67B	-2.00B	-8.40B	-2.04B	-2.65B	-3.10B	-7.18B	-3.38B	-6.77B	-8.63B	-10.15B	-10.83B
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0